Serum Beta-2 Microglobulin as Biomarker in Chronic Lymphocytic Leukemia
Background: Beta-2 microglobulin (B2M) has been identified for many years as a reliable prognostic marker in patients with chronic lymphocytic leukemia (CLL). Our study aimed to determine the serum level of B2M in Sudanese CLL patients and correlate it with other clinical and hematological parameter...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Medical Research and Development Corporation
2024-12-01
|
| Series: | International Journal of Biomedicine |
| Subjects: | |
| Online Access: | http://www.ijbm.org/articles/i56/ijbm_14(4)_oa9.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!